UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

NXY-059 for the Treatment of Acute Ischemic Stroke

The New England journal of medicine, 2007-08, Vol.357 (6), p.562-571

2007

Volltextzugriff (PDF)

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage : The CHANT trial

Stroke (1970), 2007-08, Vol.38 (8), p.2262-2269

2007

Volltextzugriff (PDF)

Early impairment in consciousness predicts mortality after hemispheric ischemic stroke

Critical care medicine, 2004, Vol.32 (1), p.241-245

2004

Volltextzugriff (PDF)

Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia

Brain research, 2006-02, Vol.1072 (1), p.224-226

2006

Volltextzugriff (PDF)

NXY-059 for Acute Ischemic Stroke

The New England journal of medicine, 2006-02, Vol.354 (6), p.588-600

2006

Volltextzugriff (PDF)

Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study

Journal of Alzheimer's disease, 2011, Vol.24 (2), p.363

2011

Volltextzugriff (PDF)

NXY-059 for the Treatment of Acute Stroke : Pooled Analysis of the SAINT I and II Trials

Stroke (1970), 2008-06, Vol.39 (6), p.1751-1758

2008

Volltextzugriff (PDF)

Three-Month Stability of the CogState Brief Battery in Healthy Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-Rate of Change Substudy (AIBL-ROCS)

Archives of clinical neuropsychology, 2013-06, Vol.28 (4), p.320-330

2013

Volltextzugriff (PDF)

Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers

Current drug targets. CNS & neurological disorders, 2005-04, Vol.4 (2), p.109

2005

Volltextzugriff (PDF)

Animal models of stroke: do they have value for discovering neuroprotective agents?

Trends in pharmacological sciences (Regular ed.), 2003-08, Vol.24 (8), p.402-408

2003

Volltextzugriff (PDF)

Rapid decline in episodic memory in healthy older adults with high amyloid-β

Journal of Alzheimer's disease, 2013-01, Vol.33 (3), p.675

2013

Volltextzugriff (PDF)

Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy: A Validation Study of Home Time as an Outcome Measure

Stroke (1970), 2011-04, Vol.42 (4), p.1046-1050

2011

Volltextzugriff (PDF)

Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059

Pharmacology & therapeutics (Oxford), 2003-12, Vol.100 (3), p.195-214

2003

Volltextzugriff (PDF)

Psychometric features of the ADAS-Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P461-P461

2013

Volltextzugriff (PDF)

P2–283: Psychometric features of the ADAS‐Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_11), p.P461-P461

2013

Volltextzugriff (PDF)

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic Stroke in the SAINT I trial

Stroke (1970), 2006-12, Vol.37 (12), p.2970-2978

2006

Volltextzugriff (PDF)

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

The Journal of nutrition, health & aging, 2012-04, Vol.16 (4), p.339-345

2012

Volltextzugriff (PDF)

Response to Letter by Proctor and Tamborello

Stroke (1970), 2007-10, Vol.38 (10)

2007

Volltextzugriff (PDF)

The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P557-P557

2012

Volltextzugriff (PDF)

P3‐277: The Australian Imaging, Biomarkers and Lifestyle‐Rate of Change sub‐study (AIBL‐ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment

Alzheimer's & dementia, 2012-07, Vol.8 (4S_Part_15), p.P557-P557

2012

Volltextzugriff (PDF)

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients

British journal of clinical pharmacology, 2003-08, Vol.56 (2), p.173-183

2003

Volltextzugriff (PDF)

Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes

Archives of neurology (Chicago), 2004-11, Vol.61 (11), p.1677

2004

Volltextzugriff (PDF)

β-amyloid dynamics in human plasma

Archives of neurology (Chicago), 2012-12, Vol.69 (12), p.1591

2012

Volltextzugriff (PDF)

An Open Study of Clomethiazole in Patients with Acute Cerebral Infarction

Cerebrovascular diseases (Basel, Switzerland), 1998-05, Vol.8 (3), p.188-190

1998

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Aged
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Neurology
(13)
Female
(12)
Male
(12)
Neurosciences & Neurology
(10)
Stroke
(8)
Stroke - Drug Therapy
(8)
Vascular Diseases And Vascular Malformations Of The Nervous System
(8)
Aged, 80 And Over
(7)
Clinical Neurology
(7)
Double-Blind Method
(7)
Middle Aged
(7)
Time Factors
(7)
Brain Ischemia - Drug Therapy
(6)
Neuroprotective Agents - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NXY-059 for the Treatment of Acute Ischemic Stroke

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage : The CHANT trial

Early impairment in consciousness predicts mortality after hemispheric ischemic stroke

Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia

NXY-059 for Acute Ischemic Stroke

Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study

NXY-059 for the Treatment of Acute Stroke : Pooled Analysis of the SAINT I and II Trials

Three-Month Stability of the CogState Brief Battery in Healthy Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-Rate of Change Substudy (AIBL-ROCS)

Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers

Animal models of stroke: do they have value for discovering neuroprotective agents?

Rapid decline in episodic memory in healthy older adults with high amyloid-β

Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy: A Validation Study of Home Time as an Outcome Measure

Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059

Psychometric features of the ADAS-Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease

P2–283: Psychometric features of the ADAS‐Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic Stroke in the SAINT I trial

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

Response to Letter by Proctor and Tamborello

The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment

P3‐277: The Australian Imaging, Biomarkers and Lifestyle‐Rate of Change sub‐study (AIBL‐ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients

Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes

β-amyloid dynamics in human plasma

An Open Study of Clomethiazole in Patients with Acute Cerebral Infarction

Proceedings of the EuBIC-MS 2020 Developers’ Meeting

Suchergebnisse filtern